Data Quality is the Key to Veeva Success: Learn Why at Veeva Summit

by Meghan Carr | Sep 9, 2026 | Events, Life Sciences, Veeva

Organizations continue to expand their use of the Veeva Vault platform across Quality, Regulatory, Clinical, and Safety functions to streamline operations, strengthen compliance, and accelerate business outcomes. It has become a central component of broader digital transformation initiatives, supported by strong governance, validated migration approaches, and long-term optimization services.

And each year, industry leaders gather at the Veeva Summit: R&D and Quality in Boston to explore new strategies, technologies, and best practices for maximizing the value of their Veeva investments. As a trusted Veeva migration partner with decades of experience supporting life sciences organizations, fme looks forward to sponsoring the Summit to share lessons learned from some of the industry’s most complex transformation programs.

The question we hear most often remains remarkably consistent: “What is the key to a successful migration to the Veeva platform?” While modern cloud technology, thoughtful configuration, and strong implementation practices are all important, the most successful programs begin long before go-live. They start with a clear understanding of the source landscape, strong governance, and a commitment to data quality.

Data Readiness and Quality Drive Long-Term Success

Organizations that achieve the greatest value from Veeva understand that migration is not simply a technical exercise that can be thrown in at the end of your Veeva program. Whether you’re implementing your first Vault application, consolidating legacy repositories, or expanding into additional Veeva modules, your business outcomes depend on the quality of the information being migrated. Accurate, complete, and well-governed data provides the foundation for compliant processes, trusted reporting, and sustainable growth.

Successful programs require a balance of strategy, governance, validation, and automation to ensure data arrives in its new environment accurately, compliantly, and ready to support the future state. fme’s migration methodology places distinctive emphasis on these efforts to ensure our clients’ long-term success.

fme Delivers More Than Migration

Every migration program comes with unique challenges. Legacy platforms contain years of accumulated content, inconsistent metadata, disconnected processes, and regulatory requirements that cannot be compromised. fme’s experience has proven that success depends on establishing scope early, validating assumptions, and applying a disciplined methodology that reduces risk throughout the migration lifecycle.

At this year’s Summit, we’ll be sharing how our proven methodologies, classification accelerators, and validation-first strategy modernizes regulated content environments with confidence. From data assessment and enrichment to migration execution, verification, and post-go-live support, our focus remains the same: helping global life sciences firms achieve predictable outcomes while maintaining compliance and business continuity.

Proven Expertise + Validated Frameworks = Predictable Outcomes

fme is much more than a migration vendor. We are a strategic partner supporting the world’s largest life sciences organizations before, during, and after transformation initiatives. Our approach spans data readiness, migration execution, validation, stabilization, and optimization, ensuring clients receive support across the end-to-end migration lifecycle.

With more than 25 years of life sciences experience, over 200 migration projects delivered globally, and technology used by the industry’s leading pharmaceutical companies, fme brings the expertise, accelerators, and governance required for enterprise-scale Veeva programs. Whether migrating hundreds of thousands or millions of records, our goal is the same: delivering compliant, high-quality migrations that position organizations for lasting success in Veeva Vault.

To deliver at the scale and speed today’s life sciences leaders require, fme pairs expert consulting with AI-powered tools and certified accelerators that de-risk, streamline, and future-proof your migration. Here are two of our powerful tools:

AI-powered Intelligent Classification Accelerator – fme’s AI-powered intelligent classification accelerator uses automation and AI to streamline metadata analysis, enrichment, and mapping, significantly reducing manual effort and accelerating the preparation of high-quality metadata ahead of migration. This ensures that your Veeva environment is not only populated with the right data, but with data that’s clean, consistent, and aligned with your business logic.

migration-center® – Complementing this is migration-center, fme’s Veeva-product-certified migration accelerator, purpose-built to simplify even the most complex, large-scale content migrations. Supporting over 250 source-to-target combinations, migration-center handles the extraction, transformation, and loading (ETL) of data from legacy systems, databases, file shares, and cloud platforms. The result is accurate, structured, and compliant data that supports your teams immediately upon deployment into Veeva.

migration-center Verify™ – Without automated verification, even small discrepancies can go unnoticed until after go-live. Verify systematically compares migrated data against the source system, identifying inconsistencies in metadata and content integrity. This helps teams detect issues and avoid costly rework or compliance risks.

Let’s Move Forward, Together

Migrating to Veeva is a strategic move that sets the foundation for your future in regulated content and data management. With fme by your side, you’re backed by decades of life sciences experience, a tailored and proven methodology, and powerful accelerators that deliver unparallelled clarity, speed, and confidence.

Download our Veeva capabilities overview below to learn more about our services, tools, and client success stories. Then, we’ll schedule a discovery meeting where we’ll discuss your current environment (or environments) and walk through the next steps for accelerating your Veeva transformation.

Download Our Veeva Capabilities

Not Attending Veeva Summit? Let’s Still Connect.

Can’t make it to Boston this year? We’ll be happy to share our key takeaways from the event, review the latest Veeva updates, and discuss how fme can support your short- and long-term goals: on your timeline, and on your terms.

Join fme at the Pharmaceutical Manufacturing World Summit

by The fme Team | Mar 24, 2026 | Business Consulting, Events, Migration Services, Technology Services

Every year, the Pharmaceutical Manufacturing World Summit in Boston brings together industry leaders, innovators, and manufacturing experts to explore the future of pharmaceutical production. As both attendees and sponsors, the fme team enjoys this unique opportunity to engage in meaningful conversations, exchange insights, and advise on the technology and data management strategies that shape Life Sciences manufacturing today. Many of the key themes that defined last year’s agenda continue to be critical topics within the industry.

Key Themes Shaping Pharmaceutical Manufacturing World Summit

Year after year, one common thread unifies the agenda: Data is the foundation of transformation for business success.

Whether enabling AI, supporting regulatory compliance, or driving operational efficiency, success depends on having trusted, structured, and accessible data across the product lifecycle. Here are some of the recent areas of focus we’ve repeatedly shared with our clients:

Data as a Strategic Asset

One of the most important points of the conference is data is no longer just operational, it’s transformational. Organizations are increasingly relying on high-quality, accessible data to drive decision-making across supply chains, manufacturing performance, and patient safety.

The ability to treat data as a strategic asset rather than a byproduct has finally been recognized as a competitive differentiator, and has been fme’s focus and mission for over 25 years. We help companies maximize the value and power of their data, ensuring it is structured, reusable, and ready to migrate into powerful solutions that unlock its full value across the enterprise.

Navigating Geopolitical Uncertainty

Global manufacturing strategies are being reshaped by shifting regulatory landscapes, trade policies, and geopolitical tensions. From increased pressure to localize production in the U.S. to evolving FDA leadership and AI regulation, companies are operating in an environment of heightened uncertainty and risk.

fme helps guide organizations through the dynamic data management challenges that can affect supply chain resilience, inspection readiness, and compliance strategies.

Infrastructure Investment and Digital Transformation

The scale of investment in modern manufacturing infrastructure is staggering. Leading pharmaceutical companies are building digitally native, highly automated facilities designed for flexibility, speed, and advanced modalities like cell and gene therapies.

Technologies such as digital twins, robotics, IIoT, and integrated MES/QMS platforms are becoming foundational. At the same time, organizations are recognizing that less than 1% of process data is often fully utilized, highlighting a major opportunity for transformation.

To ensure technology investments address both immediate and long-term needs, it is critical to work with a technology partner that understands the technical and business goals of an integrated research, development, and manufacturing pipeline.

Pricing Pressures Driving Efficiency

With rising costs across the industry, manufacturers are under pressure to do more with less. The focus has shifted toward reducing inefficiencies, eliminating rework, and accelerating system consolidation.

This is where digital enablement and automation powered by clean, high-integrity data are playing a critical role in turning compliance into a value-generating function rather than a cost center.

Innovation Accelerating at Scale

From AI-driven quality transformation to novel manufacturing platforms, innovation is rapidly reshaping the industry.

Highlights from last year included:

AI-enabled quality systems and predictive manufacturing
Expansion into advanced modalities like ADCs and cell therapies
End-to-end digital supply chain orchestration
Increasing use of GenAI to enhance quality and operational efficiency

Organizations are not just experimenting. They are scaling these innovations to drive measurable business outcomes before their competition.

Join Us at This Year’s Summit

We’re excited to return to the Pharmaceutical Manufacturing World Summit this year as a sponsor and continue the conversation with industry leaders.

If you’ll be attending, we’d love to connect! Contact us and we’ll schedule a time to discuss your current challenges, share our proven strategies and insights, or explore how to accelerate your digital and data initiatives. If you can’t attend and would like a summary of the essential topics and sessions, let us know.

Contact Us

Master Data and Governance in a New Life Sciences Reality

by The fme Team | Mar 19, 2026 | Events, Life Sciences, Migration Services

We are excited to share that fme will be joining the 12th Master Data and Data Governance Excellence In Life Sciences Conference, 4-5 June in Zurich, Switzerland. In the Life Sciences industry, data is no longer just an operational asset, it is the foundation for innovation, regulatory compliance, and commercial success. fme’s experts look forward to participating in these discussions to share our experience and strategies to rescue information from disconnected silos and align it with business goals.

Today, data is no longer a by-product of operations. It is a strategic asset that underpins innovation, regulatory compliance, and commercial success.

Across Regulatory, Clinical, Quality domains, organizations are entering a new data reality. Regulatory expectations, such as IDMP, are accelerating the need for structured, standardized, and interoperable data. At the same time, governance is evolving from control to enablement, where data must actively support processes, analytics, and decision-making. In addition, new AI solutions show amazing promise but are only as effective as the data they are built on.

This shift is redefining long-standing concepts. The idea of a single, static source of truth is giving way to dynamic, connected, and context-driven data ecosystems that must work seamlessly across systems and functions.

The Gap Between Ambition and Execution

Many organizations are investing in AI use cases, data governance frameworks, and master data management initiatives. However, execution remains a challenge.

Data is often not AI-ready.
Quality issues limit trust and reuse.
Governance frameworks exist but are not embedded in daily operations.
MDM approaches struggle to scale across domains and keep pace with increasing complexity.

This creates a disconnect between strategy and reality. Without trusted and governed data, transformation initiatives slow down, risk increases, and expected value is not fully realized.

How fme Translates Data Strategy into Execution

At fme, we help Life Sciences organizations turn data ambition into execution. Our approach focuses on building trusted data foundations that support transformation across the full lifecycle:

Data readiness and assessment

We help organizations understand their data landscape through system inventory, quality analysis, and risk identification. This creates clarity before transformation begins.

Master data and governance enablement

We support the design and operationalization of governance frameworks, including data ownership, metadata standards, and harmonization across domains. The focus is on making governance actionable in daily work.

Migration and transformation execution

With deep expertise in platforms such as Veeva Vault, Generis CARA, Documentum, and TrackWise, fme delivers controlled and compliant migrations. Our migration-center® technology enables scalable, repeatable, and auditable execution.

Data quality and remediation

We support ongoing data quality improvement, remediation, and post-go-live stabilization to ensure data remains trusted, usable, and aligned with evolving requirements.

A Practical Path Forward

Success in this new data reality requires more than technology. It requires scalable governance, high-quality data, and the ability to operationalize master data across domains.

fme combines domain expertise, proven methodology, and purpose-built technology to help organizations reduce risk, improve efficiency, and unlock the full value of their data.

Meet Us at the Conference

We look forward to connecting at the 12th Master Data and Data Governance Excellence in Life Sciences Conference and discussing how Life Sciences organizations can move from ambition to execution.

If you are navigating data complexity, regulatory pressure, or AI readiness, let’s connect. We’d love to discuss your challenges, and share our proven strategies and solutions to complex information management challenges.

Contact Us

Copenhagen is Around the Corner: Veeva R&D Summit Europe

by Meghan Carr | Feb 24, 2026 | Digital Transformation, Events, Veeva

DIA RSIDM 2026 Hot Topic: Data Quality Transformation

by The fme Team | Jan 5, 2026 | Business Consulting, Events, Life Sciences, Regulatory

An annual staple of the regulatory industry, DIA’s RSIDM brings together industry and regulatory stakeholders to discuss evolving data standards, requirements and effective data management strategies. This year, fme’s regulatory experts David Gwyn, Frank D’Entrone and Scott Coles will be attending and answering questions in Booth #116. Stop by and see us! We’d love to discuss your challenges and plans for 2026, and share our proven solutions for managing complex regulatory submissions.

The Real Story: Data Quality Transformation

As data migration experts for the Life Sciences industry, we’ve helped the world’s largest organizations move complex regulatory ecosystems into platforms and solutions that align with their business processes and goals. Through our experiences, we’ve also realized that the actual migration is only one chapter of a much larger story.

In fact, the most urgent and impactful challenges our clients face aren’t about switching platforms. They’re about the quality, readiness, governance, and trustworthiness of the data they already have. And according to our clients, that’s where fme shines far brighter than other providers and especially the newest ‘intelligent’ solutions.

We Are Data Quality Transformation Specialists

fme understands the organization and structure of a client’s data is a reflection of the meaning, use and purpose of the information embedded within. Data, metadata and content all add essential context to data, and each detail needs to be available to realize its full value.

This is why clients come to us; they recognize fme’s experts can evaluate and enrich their data before incorporating it into their technology platform and business processes. Whether it’s organizing legacy content, remediating years of inconsistent metadata, strengthening governance practices, or establishing stewardship models that scale across global regulatory teams, fme knows where to look, and how to ensure every element is structured for efficient and contextual use.

This is the work we’re doing right now—multi-million-dollar data readiness and remediation initiatives—with some of the world’s largest and most complex Life Sciences companies. These aren’t migration projects. They’re data projects that emphasize critical concepts:

Data readiness is the foundation for modernization and digital transformation.
Governance and stewardship drive regulatory confidence.
Quality transformation unlocks efficiency, compliance, and innovation.

And they reflect a reality that’s becoming impossible to ignore:
You don’t have to move to a new platform to improve. You just need better data.

Understand Where You Are First

This has been one of the biggest expansions in the strategies we use to serve our clients. A transformation doesn’t start with technology change. It starts with understanding your current state, and building the pathway to allow your data to power your business goals.

fme’s solutions like MetadataAssist℠ and HealthCheckAssist℠ are strategically designed to provide regulatory and RIM teams with a fast, structured way to evaluate:

What data exists
How clean or accurate it is
How well metadata models are applied
Where governance gaps are limiting efficiency
What improvements can be made without moving platforms

In many cases, clients discover that a migration is unnecessary, or at least not urgent. By improving their data quality and governance practices, they can dramatically increase the value of the systems they already use.

To Migrate or Not: Choosing What’s Next

Of course, some organizations ultimately decide that their current platform can’t support where they want their business to go. When that happens, we help them choose their next solution with clear quantitative and qualitative data to cut through the marketing jargon and seller-lingo that can obfuscate true capabilities and benefits.

SelectAssist℠ is a unique offering that pairs our regulatory experts with client stakeholders to guide them through detailed platform evaluations and selection based on:

Regulatory workflows
Data and metadata requirements
Change readiness
Long-term scalability
Integration and interoperability needs

It’s important to clarify that while fme has many platform partners, our goal is to guide clients to the best solution for their unique goals. We provide a holistic, data-justified perspective focused on their needs, not a quarterly sales quota.

When Migration Is the Answer, We Deliver with Precision

When the data is optimized, technology is selected, and the organization is ready to move platforms, fme’s 30 years of migration experience come into play. We have unmatched knowledge, proven methodologies and acceleration toolsets to execute seamless regulatory content and data migrations at scale most service providers have never touched.

We combine:

AI-driven automation
Proven methodologies
Industry-leading tools
Deep regulatory and compliance expertise

After hundreds of successful migration projects, we have the skill and knowledge to deliver a seamless, accurate, and validated transition first time, every time.

Learn More about Data Quality Transformation

fme is evolving along with our clients’ needs. The industry is hungry for organizations that understand not just platforms, but the data that fuels regulatory compliance, submission quality, operational efficiency, and innovation.

So when we say we’re data quality transformation specialists, we mean:

We assess.
We remediate.
We govern.
We steward.
We prepare for the future.
And yes, when it’s the right time, we migrate.

But the story always starts with data quality. Do you REALLY know yours?

If you want to understand the value your data could be delivering, or if you’re struggling to achieve efficiency and compliance with the information you already have, we’re here to help you make it happen. Download the resource below to learn more.

Download Resources

Deep Dive into Regulatory Solutions at DIA RSIDM 2025

by The fme Team | Jan 6, 2025 | Business Consulting, Events, Migration Services, Regulatory

This February, DIA RSIDM 2025 returns to Bethesda, MD, reaffirming its reputation as the premier event for regulatory professionals to exchange the best solutions for managing complex regulatory submissions. At fme, we specialize in helping pharmaceutical and biotechnology companies navigate regulatory challenges with expertise in selecting, planning, and migrating to RIM solutions tailored to their unique data, documents, and workflows. Visit us at Booth #315 during the RSIDM forum—we’d love to discuss your challenges and plans for 2025!

Operational Efficiency is Critical

Every day, pharmaceutical companies strive to demonstrate the efficacy of new discoveries and deliver life-changing medications to patients in need. To accelerate time-to-market and ensure safety, timely and high-quality regulatory submissions to health authorities are critical for review and approval.

However, the process is fraught with challenges. The sheer volume and complexity of data, documents, and information exchanged among multiple stakeholders and systems create significant hurdles in maintaining accurate, up-to-date documentation. Errors, omissions, or inconsistencies can lead to costly delays and disrupt expected release timelines.

Seasoned regulatory professionals recognize the importance of operational efficiency in managing regulatory information effectively throughout the development cycle, ensuring smooth and successful submissions.

Keys to RSIDM Efficiency and Success

Efficiency and success in regulatory operations depend on seamlessly aligning people, processes, and technology throughout a medication’s journey—from conception to patient use. With years of experience and a proven track record, fme has gained deep insights into the complexities of every phase of this journey. This expertise has enabled us to develop and refine methodologies that:

Analyze existing systems and workflows
Align requirements with tailored technology solutions
Ensure data and documents are accurately classified for discovery and use

fme’s experts combine a deep understanding of the product development lifecycle with extensive experience in regulatory projects. Staying ahead of evolving data standards, requirements, and technology trends, we guide clients toward the best solutions for today while future-proofing their decisions to deliver long-term ROI.

Download this overview to see how fme can help you achieve regulatory excellence and why we are recognized as a leader in content management solutions for regulatory environments.

Download Overview

Connect with fme at DIA RSIDM 2025

Last year, fme’s David Gwyn spoke on “Leveraging Structured Content Authoring in Regulatory Submissions: Real-World Experience, Industry Insights and Tools.” This presentation focused on the latest EDM Structured Reference Model team developments, showcasing how their work influences industry-wide adoption. For more information, view the full details of the session here.

For 2025, David will be joined by RIM experts Jonathan Byars and Frank D’Entrone to provide their expertise on effective strategies to align people, processes, and technology for RIM success. fme’s experience across platforms, industries, and global territories gives us unparalleled insights into the best strategies and solutions and how to ensure a successful journey to regulatory excellence.

What are your challenges for 2025? Use the form below to request a no-cost discovery session and we’ll schedule a time to discuss your concerns and possible solutions. If you are attending RSIDM 2025, join us at Booth #315 and we can start the conversation in person! If you can’t attend this year, download the overview and let us know if you’d like to talk.

Contact us

The DIA RSIDM 2025 Educational Tracks

The educational tracks for this year’s conference reflect the continued integrated communication challenges regulatory professionals face within a quickly evolving technology landscape. Download the overview above to learn more about how we can support your team in each.

Track 1: Building and Sustaining Successful RSIDM Foundations
- This track is designed for attendees who are either new to the field or seek a comprehensive review of the evolving dynamics and intricacies that shape their day-to-day work.
Track 2: Optimizing Processes and Procedures
- This track is tailored for intermediate-level professionals and focuses on what is needed to improve processes, procedures, and data to foster a culture of innovative practices and forward-thinking. Learn proven industry best practices and discuss the impact of new global regulations on your organization’s processes and procedures.
Track 3: Adopting Innovative Technologies
- This intermediate to advanced track provides first-hand knowledge from global regulatory health authorities on the implementation of new technologies, policies, and guidelines. It also includes perspectives on how to incorporate technology advancements like artificial intelligence and automation, and how to assess their effectiveness and impact.
Track 4: Achieving Regulatory Excellence
- This advanced track is designed for leadership roles, and includes examples and use cases from organizations that have achieved regulatory excellence. It covers a wide range of practical implementation strategies to support vision, cultural change, and commitment to innovation.

We are excited to participate in these valuable conversations with regulatory thought leaders and re-connect with industry colleagues! Find the full RSIDM 2025 agenda here, and contact us if you have any questions about the specific tracks or sessions offered. We look forward to seeing you there!